AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 65 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $446,000 | -18.9% | 83,572 | 0.0% | 0.60% | -7.7% |
| Q2 2019 | $550,000 | -12.8% | 83,572 | -13.9% | 0.65% | -25.7% |
| Q1 2019 | $631,000 | -20.9% | 97,056 | -17.1% | 0.88% | -18.6% |
| Q4 2018 | $798,000 | -29.4% | 117,056 | -31.3% | 1.08% | +1.8% |
| Q3 2018 | $1,131,000 | +17.9% | 170,356 | 0.0% | 1.06% | +20.5% |
| Q2 2018 | $959,000 | +18.4% | 170,356 | +9.1% | 0.88% | +3.5% |
| Q1 2018 | $810,000 | +14.6% | 156,126 | 0.0% | 0.85% | +17.6% |
| Q4 2017 | $707,000 | -19.4% | 156,126 | +11.6% | 0.72% | -32.8% |
| Q3 2017 | $877,000 | +116.0% | 139,937 | +111.1% | 1.07% | +74.6% |
| Q2 2017 | $406,000 | +23.0% | 66,304 | +47.3% | 0.62% | +34.6% |
| Q1 2017 | $330,000 | – | 45,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |